Olinvacimab Antibody
Olinvacimab (TTAC-0001) is a human monoclonal antibody that inhibits VEGFR-2 (KDR), exerting anti-angiogenic effects by blocking tumor blood vessel formation. It is utilized in preclinical research for studying solid tumors, with applications in both in vitro cell-based assays and in vivo xenograft models to investigate angiogenesis and tumor growth.
Product Specifications
Product Name Alternative
TTAC0001, TTAC-0001
Target
VEGFR
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Cardiovascular Research, Signal Transduction
Concentration
5.67 mg/mL
Purity
97.70% (May vary between batches)
Molecular Weight
148.16 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1220114-01 0.02 mg (E-Coli)
Recombinant Goat Cytochrome P450 2F3 (CYP2F3)
Sign In for Pricing
View Details MBS1220114-02 0.02 mg (Yeast)
Recombinant Goat Cytochrome P450 2F3 (CYP2F3)
Sign In for Pricing
View Details MBS1220114-03 0.1 mg (E-Coli)
Recombinant Goat Cytochrome P450 2F3 (CYP2F3)
Sign In for Pricing
View Details MBS1220114-04 0.1 mg (Yeast)
Recombinant Goat Cytochrome P450 2F3 (CYP2F3)
Sign In for Pricing
View Details MBS1220114-05 0.02 mg (Baculovirus)
Recombinant Goat Cytochrome P450 2F3 (CYP2F3)
Sign In for Pricing
View Details